LAS VEGAS, July 7, 2014 /PRNewswire/ -- GrowBLOX Sciences,
Inc. (OTCQB: GBLX), a biotechnology and research company, today is
pleased to announce that their largest investor, Lazarus Investment
Partners LLLP, has acquired an additional 269,632 shares in the
open market for an additional $322,000 investment. Lazarus, which already holds
a 3,000,000 share investment at a price of $0.50, averaged up their position acquiring
199,632 shares at $1.19, 50,000
shares at $1.21, and 20,000 shares at
$1.20 over a three day period from
June 30, 2014, to July 2, 2014.
Lazarus Investment Partners LLLP increasing their investment by
averaging up and acquiring additional shares in the open market
shows their belief in GrowBLOX Sciences, Inc. and our ability to
execute on our business plan. The move also proves that Lazarus
considers shares of GrowBLOX Sciences, Inc. to be undervalued at
current levels. The Company has made substantial headway in
becoming a biotechnology leader in the legal cannabis space over
the last few months which has given Lazarus the confidence to
increase their investment at a much higher price.
GrowBLOX Sciences, Inc. is excited to have a quality and
experienced investment firm like Lazarus Investment Partners LLLP
so interested in the Company. We are looking forward to continued
progression in the legal cannabis space and further developing our
relationship with Lazarus Investment Partners LLLP.
About GrowBLOX Sciences, Inc.
GrowBLOX Sciences, Inc., is a research and biotechnical company
that has developed proprietary indoor growing chambers specifically
designed for medical cannabis cultivation. The GrowBLOX chamber
allows for completely controlled growing conditions, ensuring the
manufacture of a consistent, toxin-free, natural and
medicinal-grade product. The Company believes that the advantages
of a controlled environment over traditional outdoor or greenhouse
growing, will empower the public, nutraceutical and pharmaceutical
industries to embrace cannabis as an effective treatment for a
myriad of serious medical
conditions. http://www.gbsciences.com
About Lazarus Investment Partners LLLP
Lazarus Investment Partners LLLP makes open market purchases of
ultra-small microcap public companies with market capitalizations
of $140 million or less. Lazarus
exclusively invests within the United
States. It manages assets from a diverse group of investors
which includes high net worth individuals, corporations, investment
companies and other institutions. The firm was founded in
May 2003 and is located in
Denver, Colorado.
Forward-Looking Statements
Except for historical information contained herein, the
statements in this release are forward-looking and made pursuant to
the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. Forward-looking statements are inherently
unreliable and actual results may differ materially. Examples
of forward-looking statements in this news release include
statements regarding the payment of dividends, marketing and
distribution plans, development activities and anticipated
operating results. Factors which could cause actual results to
differ materially from these forward-looking statements include
such factors as the Company's ability to accomplish its business
initiatives, significant fluctuations in marketing expenses and
ability to achieve and expand significant levels of revenues, or
recognize net income, from the sale of its products and services,
as well as the introduction of competing products, or management's
ability to attract and maintain qualified personnel necessary for
the development and commercialization of its planned products, and
other information that may be detailed from time to time in the
Company's filings with the United States Securities and Exchange
Commission. The Company undertakes no obligation to publicly update
or revise any forward-looking statements, whether as a result of
new information, future events or otherwise.
Contact:
Jonathan Barkman
Riverview Capital Enterprises
+1-866-845-0105
SOURCE GrowBLOX Sciences, Inc.